{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:05:31Z","timestamp":1790975131603,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ijid.2021.05.061","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T23:17:21Z","timestamp":1622503041000},"page":"465-472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial"],"prefix":"10.1016","volume":"108","author":[{"given":"Sodiomon B.","family":"Sirima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alphonse","family":"Ouedraogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5454-0748","authenticated-orcid":false,"given":"Nouhoun","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamadou","family":"Siribie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Tiono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issa","family":"N\u00e9bi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amadou","family":"Konat\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria Damoaliga","family":"Berges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amidou","family":"Diarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moussa","family":"Ouedraogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith C.","family":"Bougouma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issiaka","family":"Soulama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5896-4927","authenticated-orcid":false,"given":"Alimatou","family":"Hema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrimati","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3048-722X","authenticated-orcid":false,"given":"Elizabeth T.","family":"Rotrosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Kathleen","family":"Tracy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie P.","family":"Jamka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6919-6780","authenticated-orcid":false,"given":"Jennifer J.","family":"Oshinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0894-4009","authenticated-orcid":false,"given":"Marcela F.","family":"Pasetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Neuzil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3874-581X","authenticated-orcid":false,"given":"Matthew B.","family":"Laurens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijid.2021.05.061_bib0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/jtm.12164","article-title":"Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults","volume":"22","author":"Alberer","year":"2015","journal-title":"J Travel Med"},{"key":"10.1016\/j.ijid.2021.05.061_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2020.100074","volume":"6","author":"Capeding","year":"2020","journal-title":"Vaccine X"},{"issue":"6","key":"10.1016\/j.ijid.2021.05.061_bib0015","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/infdis\/jiw225","article-title":"Sporozoite route of infection influences in vitro var gene transcription of Plasmodium falciparum parasites from controlled human infections","volume":"214","author":"Dimonte","year":"2016","journal-title":"J Infect Dis"},{"issue":"10258","key":"10.1016\/j.ijid.2021.05.061_bib0020","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Diseases","year":"2020","journal-title":"Lancet"},{"issue":"10258","key":"10.1016\/j.ijid.2021.05.061_bib0025","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ijid.2021.05.061_bib0030","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4269\/ajtmh.13-0264","article-title":"Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years","volume":"89","author":"Gotuzzo","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.ijid.2021.05.061_bib0035","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/infdis\/jiy215","article-title":"Evaluation of a booster dose of pentavalent rotavirus vaccine coadministered with measles, yellow fever, and meningitis A vaccines in 9-month-old Malian infants","volume":"218","author":"Haidara","year":"2018","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2021.05.061_bib0040","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.vaccine.2016.11.075","article-title":"Vaccine coverage and adherence to EPI schedules in eight resource poor settings in the MAL-ED cohort study","volume":"35","author":"Hoest","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2021.05.061_bib0045","series-title":"Global burden of disease, typhoid fever \u2014 level 4 cause","author":"Institute for Health Metrics and Evaluation","year":"2020"},{"issue":"10111","key":"10.1016\/j.ijid.2021.05.061_bib0050","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ijid.2021.05.061_bib0055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s13312-020-1890-y","article-title":"Immunogenicity and safety of typhoid conjugate vaccine in healthy Indian subjects: a randomized, active-controlled, comparative clinical trial","volume":"57","author":"Kundu","year":"2020","journal-title":"Indian Pediatr"},{"issue":"Suppl. 2","key":"10.1016\/j.ijid.2021.05.061_bib0060","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1093\/cid\/ciy1104","article-title":"A phase II, randomized, double-blind, controlled safety and immunogenicity trial of typhoid conjugate vaccine in children under 2 years of age in Ouagadougou, Burkina Faso: a methods paper","volume":"68","author":"Laurens","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"44","key":"10.1016\/j.ijid.2021.05.061_bib0065","doi-asserted-by":"crossref","first-page":"e1721","DOI":"10.1097\/MD.0000000000001721","article-title":"Combination measles-mumps-rubella-varicella vaccine in healthy children: a systematic review and meta-analysis of immunogenicity and safety","volume":"94","author":"Ma","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.ijid.2021.05.061_bib0070","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2214-109X(17)30022-0","article-title":"Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study","volume":"5","author":"Marks","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijid.2021.05.061_bib0075","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41541-019-0135-3","article-title":"Harmonization of Zika neutralization assays by using the WHO International Standard for anti-Zika virus antibody","volume":"4","author":"Mattiuzzo","year":"2019","journal-title":"NPJ Vaccin"},{"key":"10.1016\/j.ijid.2021.05.061_bib0080","article-title":"Vaccines for preventing typhoid fever","volume":"5","author":"Milligan","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ijid.2021.05.061_bib0085","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"19","key":"10.1016\/j.ijid.2021.05.061_bib0090","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1016\/j.vaccine.2020.03.028","article-title":"Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad, Pakistan","volume":"38","author":"Qamar","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2021.05.061_bib0095","series-title":"Background paper to SAGE on typhoid vaccine policy recommendations","author":"SAGE Working Group on Typhoid Vaccines & the WHO Secretariat","year":"2017"},{"issue":"23","key":"10.1016\/j.ijid.2021.05.061_bib0100","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1905047","article-title":"Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal","volume":"381","author":"Shakya","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ijid.2021.05.061_bib0105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clim.2011.02.003","article-title":"Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates","volume":"139","author":"Simon","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ijid.2021.05.061_bib0110","article-title":"Safety and immunogenicity of co-administration of meningococcal type A and measles rubella vaccines with typhoid conjugate vaccine in children aged 15\u201323 months in Burkina Faso","author":"Sirima","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2021.05.061_bib0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4269\/ajtmh.2005.73.26","article-title":"A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali","volume":"73","author":"Tapia","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.ijid.2021.05.061_bib0120","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ng.3281","article-title":"Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events","volume":"47","author":"Wong","year":"2015","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.ijid.2021.05.061_bib0125","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vaccine.2018.04.022","article-title":"Typhoid vaccines: WHO position paper, March 2018 \u2014 recommendations","volume":"37","author":"World Health Organization","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2021.05.061_bib0130","series-title":"Measles \u2014 global situation","author":"World Health Organization","year":"2019"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221004616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221004616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:01:38Z","timestamp":1761120098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221004616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":26,"alternative-id":["S1201971221004616"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.05.061","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.05.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}